APR 26, 2016 9:39 AM PDT

Pancreatic Tumors Spurred On By Cell Death

WRITTEN BY: Xuan Pham
Human PDAC tumors shows co-expression of CXCL1 (red) and CK19 (green; a marker of PADC) by confocal microscopy.Cancer cells may actually be spurred on by the death of nearby cells, reported scientists at the NYU Langone Medical Center. In a bizarre and paradoxical twist, they found that cancer cells thrive on chemical signals released by cells undergoing an orchestrated death event known as necroptosis. Knowing this highlights the importance of studying cancer in the context of its biological system, and could point researchers to new anti-cancer targets.
 
The cells in our bodies are equipped to die when they’re too old or have acquired to many damages or mutations. This biological “self-destruct” mechanism prevents mutated cells from propagating and harming the host. In contrast to the orderly process of programmed cell death induced by apoptosis, cells that die via necrosis experience a messier fate whereby their contents spill into the surrounding environment. This can trigger inflammatory responses that are otherwise absent in apoptosis. Cells can also undergo programmed necrosis – a process known as necroptosis.
 
Despite these checkpoints, cancer notoriously evades cell death, proliferating despite its many mutations. And it may do so by taking in chemical signals from its dead neighbors.
 
The research team, led by George Miller at the NYU Langone Medical Center, focused on pancreatic ductal adenocarcinoma (PDAC) – the most aggressive form of pancreatic cancer to diagnose and treat.
 
They found that dying tumor cells release small proteins called CXCL1, which attract and trap immune cells to prevent them from destroying the cancer cells. The PDAC tumor cells, in turn, use CXCL1 to drive its own tumor growth.
 
"Our findings are the first to show that cancer cell death via necroptosis can actually promote tumor growth, as this process results in suppression of the body's immune response against the cancer," said George Miller, associate professor in the Departments of Surgery and Cell Biology, and senior study author. "What is equally significant is that these findings might also be relevant to other tumor types."
 
In addition to CXCL1, they also found that dying tumor cells also release another protein, SAP130, which activates inflammatory immune cells. They found this activation spurred PDAC tumor growth in mice.
 
"This study exemplifies the importance of examining cancer within the actual context in which it grows," said Gregor Werba, co-first author of the study. "In our initial studies, inhibiting necroptosis in PDAC cells increased their ability to grow in tissue culture. However, when we began to study the same process in mice, we were surprised to see just the opposite effect, and this was mainly due to the immune response of the cells surrounding the tumor." Thus, the team is hopeful to discover new targets for inhibiting cancer growth in the necroptosis pathway. 
 

 Additional source: Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
FEB 11, 2021
Clinical & Molecular DX
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
FEB 11, 2021
Seeing if Hormone Therapy Will Work for Breast Cancer Patients
Only around half of women diagnosed with breast cancer will benefit from hormonal therapy, a cancer treatment that adds, ...
FEB 04, 2021
Cancer
Microchip models tumor‐immune interactions to predict immunotherapy effectiveness
FEB 04, 2021
Microchip models tumor‐immune interactions to predict immunotherapy effectiveness
A team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a microchip system that models immune ...
MAR 11, 2021
Cell & Molecular Biology
Deadly Cancer Cells Can Move in the Wrong Direction
MAR 11, 2021
Deadly Cancer Cells Can Move in the Wrong Direction
Cancer is most deadly when it metastasizes; when cells break away from a primary site of cancer and move through the bod ...
MAR 29, 2021
Cancer
Modeling metastasis
MAR 29, 2021
Modeling metastasis
Novel research published in Genome Biology investigates the cellular mechanisms at work during cancer metastasis using n ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
APR 05, 2021
Cannabis Sciences
Can Smoking Cannabis Cause Lung Cancer?
APR 05, 2021
Can Smoking Cannabis Cause Lung Cancer?
So far, there is no firm consensus on whether smoking cannabis can cause lung cancer. As cannabis smoke contains many si ...
Loading Comments...